HNRNPC has been identified as an oncogene, enhancing deterioration in multiple tumor types, including gastric cancer (29), breast cancer (27), esophageal squamous cell carcinoma (26), and oral squamous cell carcinoma (30). The gene discussed is HNRNPC; the disease is breast carcinoma.